an hour ago
First human trial of Bundibugyo Ebola vaccine begins
The world’s first clinical trial of a vaccine targeting the Bundibugyo strain of Ebola has begun, marking a milestone in efforts to contain an outbreak that has killed more than 700 people in central Africa. The early-stage trial will enroll 50... Read more.
Owner: Lozan Ulyana Ivanovna through UNN Information Agency LLC
Owner: Larry Solov, Susie Breitbart and The Mercer Family through Breitbart News Network LLC
Owner: Apollo Global Management (Vanguard Group, Largest Shareholder) through Yahoo, Inc.
More from The Japan Times
Owner: News2u Holdings Corporation (Minako Suematsu, Chair)
Owner: News2u Holdings Corporation (Minako Suematsu, Chair)
Owner: News2u Holdings Corporation (Minako Suematsu, Chair)
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
